Clin Mol Hepatol.  2025 Apr;31(2):658-661. 10.3350/cmh.2025.0155.

Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Affiliations
  • 1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • 2Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
  • 3Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan
  • 4Department of Internal Medicine, National Taiwan University Biomedical Park Hospital, Hsin-Chu, Taiwan

Keyword

Hepatitis C virus; Type 2 diabetes; Dyslipidemia; Liver stiffness measurement; FIB-4 index
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr